Gordon Research Conferences
PI_Conferences PI_Conferences_Current
Conference Program
 
Angiotensin (GRS)
Gordon Research Seminar
New Developments in the RAS: From Bench to Bedside
March 1-2, 2014
Renaissance Tuscany Il Ciocco Resort
Lucca (Barga), Italy
Chair:
Sean E. Thatcher

Associate Chair:
Candice M. Thomas

Related Meeting Information
The Angiotensin Gordon Research Seminar was held in conjunction with the Angiotensin Gordon Research Conference. Please refer to the Angiotensin GRC web page for more information.

The Gordon Research Seminar on Angiotensin is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.

The focus of this meeting will be on therapies targeting the new components of the RAS; bridging the gap between basic research and clinical efficacy in pathological conditions, such as in diabetes and obesity, hypertension, aging, heart and renal failure, and auto-immune diseases.


Contributors

SATURDAY
1:30 pm - 4:30 pmArrival and Check-in
3:00 pm - 3:15 pmIntroductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair
3:15 pm - 4:00 pmKeynote Session
Discussion Leader: Sean Thatcher (University of Kentucky)
3:15 pm - 3:45 pmDominik Mueller (Max-Delbruck-Centrum, Berlin, Germany)
"Unpredictable Results - The Big Chance in Science"
3:45 pm - 4:00 pmDiscussion
4:00 pm - 5:30 pmPoster Session I
5:30 pm - 7:30 pmThe RAS and Diabetes
Discussion Leaders: Rajesh Kumar and Candice Thomas (Texas A&M Health Science Center, Temple, TX)
5:30 pm - 5:50 pmCandice Thomas (Texas A&M Health Science Center)
"The Cardiac Renin Angiotensin System in Diabetes"
5:50 pm - 6:00 pmDiscussion
6:00 pm - 6:20 pmKatrina Binger (Max-Delbrueck Center for Molecular Medicine, Berlin, Germany)
"(Pro)renin Receptor Conditional Knockout Causes Beta-Cell Loss and Hyperglycemia by Inducing Pathological Autophagy"
6:20 pm - 6:30 pmDiscussion
6:30 pm - 6:50 pmRobin Shoemaker (Graduate Center for Nutritional Sciences, University of Kentucky)
"ACE2 Deficiency Augments the Development of Type 2 Diabetes in Obese Mice"
6:50 pm - 7:00 pmDiscussion
7:00 pm - 7:20 pmJuliana Colucci (Universidade Federal de São Paulo, Sao Paulo, Brazil)
"Difference Between ACE/ACE2 Balance in Diabetic Mice Harboring One or Three Copies of Angiotensin Converting Enzyme Gene"
7:20 pm - 7:30 pmDiscussion
8:00 pmDinner
SUNDAY
7:30 am - 8:30 amBreakfast
9:00 am - 11:00 amNew Therapeutics for the RAS: Targeting the ACE2/Ang-(1-7)/MasR and AT2 Receptor Pathways
Discussion Leaders: Kathryn Sandberg (Georgetown University, Washington DC) and Jan Danser (Erasmus MC, Rotterdam, Netherlands)
9:00 am - 9:20 amRodrigo Fraga-Silva (Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland)
"ACE2 Activators for Cardiovascular Diseases"
9:20 am - 9:30 amDiscussion
9:30 am - 9:50 amRobert Regenhardt (University of Florida, Gainesville, FL)
"Transcriptomic Modeling of the Cerebroprotective Effects of AT2R Agonist Compound 21 in Ischemic Stroke"
9:50 am - 10:00 amDiscussion
10:00 am - 10:20 amEmma Jones (Monash University, Melbourne, Australia)
"Pharmacology of Novel AT2 Receptor Agonists"
10:20 am - 10:30 amDiscussion
10:30 am - 10:50 amGerry Wagenaar (Leiden University Medical Center, Leiden, Netherlands)
"Intervening in AT2 Signalling Attenuates Hyperoxia-Induced Lung and Heart Injury in Newborn Rats"
10:50 am - 11:00 amDiscussion
11:00 am - 12:30 pmPoster Session II
Coffee will be served in the poster area from 11:00 am - 11:30 am
12:30 pmLunch
1:30 pm - 2:30 pmNew Developments and Signaling in the RAS
Discussion Leaders: Alan Daugherty (University of Kentucky, Lexington, KY) and Johannes Stegbauer (UKD, Dusseldorf, Germany)
1:30 pm - 1:50 pmEva Königshausen (UKD, Dusseldorf, Germany)
"Ang II Promotes Beta-Arrestin 2 Mediated Endocytosis in Podocytes"
1:50 pm - 2:00 pmDiscussion
2:00 pm - 2:20 pmQian Chen Yong (Texas A&M Health Science Center, Temple, TX)
"Hydrogen Sulfide Inhibits the Activation of the Renin-Angiotensin System in Diabetic Heart"
2:20 pm - 2:30 pmDiscussion
2:30 pm - 3:00 pmEvaluation Period
Fill in GRS Evaluation Forms
3:00 pmGordon Research Seminar ends. For those attending the associated Gordon Research Conference, please check in at the GRC Office beginning at 4:00 pm.

Funding for this conference was made possible (in part) by 1R13HL121852-01A1 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Last Updated: February 25, 2014
 
© 2014 Gordon Research Conferences Search | Contact | Terms of Use | Privacy Policy | Follow us: Facebook Twitter